| AD | Alzheimer’s disease |
| Aβ | Amyloid-β |
| NFTs | Neurofibrillary tangles |
| APP | Amyloid precursor protein |
| AICD | APP intracellular domain |
| APOE | Apolipoprotein E |
| AChE | Acetylcholinesterase |
| MAP | Microtubule-associated protein |
| MTs | Microtubules |
| NF-κB | Nuclear factor kappa-B |
| ACh | Acetylcholine |
| OS | Oxidative stress |
| ROS | Reactive oxygen species |
| ER | Endoplasmic reticulum |
| HO-1 | Heme oxygenase-1 |
| NQO-1 | NAD(P)H:quinone oxidoreductase 1 |
| CAT | Catalase |
| SOD | Superoxide dismutase |
| GPx | Glutathione peroxidase |
| SNP | Sodium nitroprusside |
| NO | Nitric oxide |
| MAPK | Mitogen-activated protein kinase |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| Keap1 | Kelch-like ECH-associated protein 1 |
| NAC | N-acetylcysteine |
| BDNF | Brain-derived neurotrophic factor |
| ATP | Adenosine triphosphate |
| GSH-Px | Glutathione peroxidase |
| GSH | Glutathione |
| MDA | Malondialdehyde |
| GSSG | Oxidized glutathione |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NMDA | N-methyl-D-aspartate |
| LPS | Lipopolysaccharide |
| PGE2 | Prostaglandin E2 |
| MCP-1 | Monocyte chemoattractant protein-1 |
| p-IκBα | Phosphorylated inhibitor of κB α |
| p-p65 | Phosphorylated p65 |
| PAT | Passive avoidance task |
| MWM | Morris water maze |
| IC50 | Half-maximal inhibitory concentration |
| EF | Electric foot shock |
| ERK1/2 | Extracellular signal-regulated kinase |
| CREB | CAMP response element-binding protein |
| Gsk3β | Glycogen synthase kinase 3β |
| FSP1 | Ferroptosis suppressor protein 1 |
| INDO | Inhibiting indomethacin |
| GI | Gastrointestinal |
| BBB | Blood–brain barrier |
| SMEDDS | Self-microemulsifying drug delivery systems |
| SAR | Structure–activity relationship |
| CETSA | Cellular thermal shift assay |
| DARTS | Drug affinity responsive target stability |